NCT04941755View on ClinicalTrials.gov

A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 25, 2021

Primary Completion Date

September 24, 2021

Study Completion Date

September 24, 2021

Conditions
Healthy Participants
Interventions
DRUG

BMS-986256

Specified dose on specified days

DRUG

Famotidine

Specified dose on specified days

Trial Locations (1)

78744

PPD Development, LP, Austin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04941755 - A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants | Biotech Hunter | Biotech Hunter